Cargando…
High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
Coronavirus disease 2019 (COVID-19) in patients with severe impairment of kidney function is associated with high mortality. We evaluated the effect of high dependency renal unit (HDRU), with nephrologists as primary care physicians, as a quality improvement initiative for the management of these pa...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439625/ https://www.ncbi.nlm.nih.gov/pubmed/36107561 http://dx.doi.org/10.1097/MD.0000000000030423 |
_version_ | 1784782105178275840 |
---|---|
author | Thakare, Sayali Modi, Tulsi Gandhi, Chintan Bose, Sreyashi Deb, Satarupa Katyal, Abhinav Saxena, Nikhil Patil, Ankita Patil, Sunil Pajai, Atim Bajpai, Divya Jadhav, Pratap Jamale, Tukaram |
author_facet | Thakare, Sayali Modi, Tulsi Gandhi, Chintan Bose, Sreyashi Deb, Satarupa Katyal, Abhinav Saxena, Nikhil Patil, Ankita Patil, Sunil Pajai, Atim Bajpai, Divya Jadhav, Pratap Jamale, Tukaram |
author_sort | Thakare, Sayali |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) in patients with severe impairment of kidney function is associated with high mortality. We evaluated the effect of high dependency renal unit (HDRU), with nephrologists as primary care physicians, as a quality improvement initiative for the management of these patients. This was a quasi-experimental observational study conducted at a tertiary care hospital in western India. Patients hospitalized for COVID-19 with pre-existing end-stage-renal-disease and those with severe AKI requiring dialysis (AKI-D) were included. For the first 2 months, these patients were cared for in medical wards designated for COVID-19, after which HDRU was set up for their management. With nephrologists as primary care providers, the 4 key components of care in HDRU included: care bundles focusing on key nephrology and COVID-19 related issues, checklist-based clinical monitoring, integration of multi-specialty care, and training of nurses and doctors. Primary outcome of the study was in-hospital mortality before and after institution of the HDRU care. Secondary outcomes were dialysis dependence in AKI-D and predictors of death. A total of 238 out of 4254 (5.59%) patients with COVID-19, admitted from 28th March to 30th September 2020, had severe renal impairment (116 AKI-D and 122 end-stage-renal-disease). 145 (62%) had severe COVID-19. From 28th May to 31st August 2020, these patients were managed in HDRU. Kaplan–Meier analysis showed significant improvement in survival during HDRU care [19 of 52 (36.5%) in pre-HDRU versus 35 of 160 (21.9%) in HDRU died, P ≤ .01]. 44 (67.7%) AKI-D survivors were dialysis dependent at discharge. Breathlessness and altered mental status at presentation, development of shock during hospital stay, and leukocytosis predicted mortality. HDRU managed by nephrologists is a feasible and potentially effective approach to improve the outcomes of patients with COVID-19 and severe renal impairment. |
format | Online Article Text |
id | pubmed-9439625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94396252022-09-06 High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease Thakare, Sayali Modi, Tulsi Gandhi, Chintan Bose, Sreyashi Deb, Satarupa Katyal, Abhinav Saxena, Nikhil Patil, Ankita Patil, Sunil Pajai, Atim Bajpai, Divya Jadhav, Pratap Jamale, Tukaram Medicine (Baltimore) Research Article Coronavirus disease 2019 (COVID-19) in patients with severe impairment of kidney function is associated with high mortality. We evaluated the effect of high dependency renal unit (HDRU), with nephrologists as primary care physicians, as a quality improvement initiative for the management of these patients. This was a quasi-experimental observational study conducted at a tertiary care hospital in western India. Patients hospitalized for COVID-19 with pre-existing end-stage-renal-disease and those with severe AKI requiring dialysis (AKI-D) were included. For the first 2 months, these patients were cared for in medical wards designated for COVID-19, after which HDRU was set up for their management. With nephrologists as primary care providers, the 4 key components of care in HDRU included: care bundles focusing on key nephrology and COVID-19 related issues, checklist-based clinical monitoring, integration of multi-specialty care, and training of nurses and doctors. Primary outcome of the study was in-hospital mortality before and after institution of the HDRU care. Secondary outcomes were dialysis dependence in AKI-D and predictors of death. A total of 238 out of 4254 (5.59%) patients with COVID-19, admitted from 28th March to 30th September 2020, had severe renal impairment (116 AKI-D and 122 end-stage-renal-disease). 145 (62%) had severe COVID-19. From 28th May to 31st August 2020, these patients were managed in HDRU. Kaplan–Meier analysis showed significant improvement in survival during HDRU care [19 of 52 (36.5%) in pre-HDRU versus 35 of 160 (21.9%) in HDRU died, P ≤ .01]. 44 (67.7%) AKI-D survivors were dialysis dependent at discharge. Breathlessness and altered mental status at presentation, development of shock during hospital stay, and leukocytosis predicted mortality. HDRU managed by nephrologists is a feasible and potentially effective approach to improve the outcomes of patients with COVID-19 and severe renal impairment. Lippincott Williams & Wilkins 2022-09-02 /pmc/articles/PMC9439625/ /pubmed/36107561 http://dx.doi.org/10.1097/MD.0000000000030423 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Research Article Thakare, Sayali Modi, Tulsi Gandhi, Chintan Bose, Sreyashi Deb, Satarupa Katyal, Abhinav Saxena, Nikhil Patil, Ankita Patil, Sunil Pajai, Atim Bajpai, Divya Jadhav, Pratap Jamale, Tukaram High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease |
title | High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease |
title_full | High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease |
title_fullStr | High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease |
title_full_unstemmed | High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease |
title_short | High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease |
title_sort | high dependency renal unit for the management of covid-19 in patients with severe acute or chronic kidney disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439625/ https://www.ncbi.nlm.nih.gov/pubmed/36107561 http://dx.doi.org/10.1097/MD.0000000000030423 |
work_keys_str_mv | AT thakaresayali highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT moditulsi highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT gandhichintan highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT bosesreyashi highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT debsatarupa highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT katyalabhinav highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT saxenanikhil highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT patilankita highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT patilsunil highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT pajaiatim highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT bajpaidivya highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT jadhavpratap highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease AT jamaletukaram highdependencyrenalunitforthemanagementofcovid19inpatientswithsevereacuteorchronickidneydisease |